Nearly every Hall of Fame election I’ve participated in sadly has been dominated by the issue that plagued baseball for an entire generation: performance-enhancing drugs. With so many great players tainted by PED connections, most of the toughest calls I had to make in my previous 13 Baseball Writers' Association of America ballots required me to invoke the Hall’s longstanding off-the-field criteria, which instruct voters to consider character, integrity and sportsmanship in addition to playing performance.
The good news: There were still a few lingering PED cases on the 2024 ballot, but not many. And all of them concerned players who have been on this ballot for many years, so there wasn’t a whole lot of new research that needed to be considered.
That did not, however, make the 2024 ballot easy. Quite the opposite, because for the first time in a long time, there were a number of really difficult decisions to be made strictly on a player’s on-field performance. Which, to be honest, is how it should be. This is supposed to be the ultimate baseball debate: Is Player X a Hall of Famer or not? And it’s such a better debate when the question involves on-field performance and only on-field performance.
This was actually a smaller ballot than has been typical since I started doing this: Only 26 players up for election, 12 of those first-time nominees who retired five years ago, the other 14 returning candidates who continued to receive at least 5 percent support for up to 10 years of eligibility. As always, a player must be named on 75 percent of the roughly 400 ballots sent out to writers who have been active members of the BBWAA at least 10 years to earn induction into Cooperstown.
And it was refreshing to learn tonight that three players crossed the magic threshold and earned induction: Adrián Beltré, Joe Mauer and Todd Helton. Those three all-time greats will join Jim Leyland, who was elected last month by the Contemporary Era Committee, on the stage in Cooperstown this summer.